文献速递腹部泌尿生殖CTUS

CT脾脏体积测量能否作为预测移植肾功能的新影像生物标志物

Could CT spleen volumetry be a novel biomarker for predicting renal graft function?
PubMed 文献 · Abdom Radiol (NY) · 2025-11-24

回顾性纳入76例肾移植受者,术前行腹部平扫CT及术后6个月CT和肾多普勒超声,测量脾脏与移植肾体积并记录术后1、6个月肾动脉阻力指数,以术后12个月较1个月GFR下降≥10 mL/min/1.73 m²定义移植肾功能下降,分析脾脏体积及其变化与移植肾功能的关系。

要点

  • 术前脾脏体积较小者术后1年内移植肾功能下降风险更高(p=0.021)。
  • 术后6个月脾脏体积较前下降者,12个月时移植肾功能更差(p=0.004)。
  • 移植肾体积及其变化与移植肾功能无显著关联。

核心结论

  • 脾脏体积变化可能反映肾移植患者系统性免疫激活增强及免疫储备受限,提示脾脏作为影像生物标志物在移植后免疫动态中的桥梁作用。
  • 常规CT脾脏体积测量可能提供一种简便易得的新指标,用于预测移植后第一年内移植肾功能下降。

研究设计与样本

  • 回顾性研究,纳入76例肾移植受者,术前及术后6个月行腹部平扫CT和肾多普勒超声。
  • 在CT上测量脾脏与移植肾体积,术后1个月和6个月记录肾动脉阻力指数(RI)。
  • 以术后1个月和12个月肾小球滤过率评估移植肾功能下降,定义为GFR下降≥10 mL/min/1.73 m²。

诊断标准与关键数值

  • 移植肾功能下降定义为术后1个月至12个月GFR下降≥10 mL/min/1.73 m²。
  • 移植肾功能下降组术前RI较高(p=0.020)、术后6个月RI较高(p=0.030)、RI变化较大(p=0.010)。
  • 移植肾功能下降组术前脾脏体积较小(p=0.021)。
  • 术后6个月脾脏体积下降者12个月时移植肾功能更差(p=0.004)。

临床应用与阅片要点

  • 肾移植受者术前及术后随访CT时可关注脾脏体积及其变化,作为移植肾功能下降的潜在影像参考指标。
  • 移植肾体积及其变化在本研究中与移植肾功能无显著关联,阅片时不宜单独据此判断移植肾功能。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate whether spleen volume and its changes on imaging could serve as novel, noninvasive biomarker and predictor of renal graft function within the first post-transplant year, and to compare their prognostic performance with conventional imaging parameters such as the renal artery resistive index (RI) for predicting graft function decline.

MATERIAL AND METHOD: This retrospective study included 76 renal transplant recipients who had preoperative and 6-month postoperative non-contrast abdominal CT and renal Doppler ultrasonography. Spleen and graft volumes were measured volumetrically on CT, while RI was recorded at 1 and 6 months postoperatively. Changes in RI and spleen/graft volumes were calculated. Glomerular filtration rate at months 1 and 12 was used to determine graft function decline, defined as a ≥ 10 mL/min/1.73 m² GFR decrease. Associations between these parameters were analyzed using non-parametric statistics.

RESULTS: Patients with graft function decline exhibited higher preoperative (p = 0.020) and 6-month RI (p = 0.030) values and greater RI changes (p = 0.010). Also, these patients had smaller preoperative spleen volumes (p = 0.021). Patients with decreasing follow-up spleen volume at months 6 had poorer graft function at months 12 (p = 0.004). Graft volume and its change showed no significant association with graft function.

CONCLUSION: Spleen volume changes could reflect heightened systemic immune activation and limited immunologic reserve for renal transplant patients. This highlights the underrecognized bridging radiologic and immunologic role of the spleen as imaging biomarker into post-transplant immunodynamics. Routine CT spleen volumetry could offer a novel, easily accessible predictor of renal allograft function decline within first year-redefining the role of spleen in immune monitoring after renal transplantation.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Çamur E, Ölçücüoğlu E, Güneş YC, et al. Could CT spleen volumetry be a novel biomarker for predicting renal graft function? Abdom Radiol (NY). 2025. PMID: 41276639. doi:10.1007/s00261-025-05304-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。